- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00190190
Internal Limiting Membrane Peeling for Large Macular Holes
Comparison of the Success Rate of a Procedure With Peeling of Limiting the Intern of the Retina Versus a Traditional Procedure Without Peeling of Limiting, at Patients Presenting a Macular Hole.
Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.
Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at third postoperative month is higher in the ILM peeling group.
Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.
Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.
Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.
Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at three postoperative months is higher in the ILM peeling group.
Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.
Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.
Secondary objectives: - Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI. - Gain of ETDRS visual acuity in the third postoperative month.- Progression of cataract - Frequency of the complications.
Number of subjects and duration of the study: 80 patients older than 18 yo , presenting a macular hole > 400 µm, divided into two parallel groups will be included and followed up 3 months. The estimated total duration of the study is 27 months.
Statistical analysis: The percentages of success in the 2 groups will be compared by a Chi ² or Fisher exact test. The test Q of COCHRAN will be used to take into account the ordered character of the categories.
Intermediate Analysis: An intermediate analysis is envisaged. The procedure of adjustment of the risk of Lan and DeMets will be used.
Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Paris, Frankrike, 75010
- Service d'Ophtalmolgie de l'Hôpital Lariboisière
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age equal to or higher than 18 years
- Patient presenting a TM idiopathic of stage 2, 3 or 4
- Macular hole > 400 µm in diameter
- Patient having been informed of the objectives and constraints of the study and having signed an informed consent
Exclusion Criteria:
- Patient age < 18 years.
- Patient having a strong myopia of the operated eye: correction carried or optimal >6 dioptres
- Patient MONOPHTHALMIA.
- Patient pseudophakia presenting an "insufficient" plan capsular CRYTALLINE.
- Patient presenting a cataract making impossible a good visualization of the bottom of eye.
- Patient presenting an important opacification capsular.
- Patient presenting an associated ocular pathology being able to interfere with the operation.
- Patient presenting a TM already operated of the eye to include
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: 1
With Peeling of Limiting the Intern of the Retina
|
With Peeling of Limiting the Intern of the Retina
|
Aktiv komparator: 2
Traditional Procedure Without Peeling of Limiting
|
Traditional Procedure Without Peeling of Limiting
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
percentage of success (anatomical closing, confirmed by OCT) at third postoperative month, in both groups
Tidsramme: at 3 months
|
at 3 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI.
Tidsramme: at 3 months
|
at 3 months
|
Gain of ETDRS visual acuity in the third postoperative month
Tidsramme: at 3 months
|
at 3 months
|
Progression of cataract
Tidsramme: at 3 months
|
at 3 months
|
Frequency of the complications.
Tidsramme: at 3 months
|
at 3 months
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Ramin TADAYONI, MD, Assistance Publique - Hôpitaux de Paris
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- P040604
- PS040604
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på With Peeling of Limiting the Intern of the Retina
-
Memorial Sloan Kettering Cancer CenterAvsluttetFamiliene eller pårørende til pasienter behandlet ved MSKCC for ikke-kutane plateepitelkarsinomer i | Øvre fordøyelseskanalForente stater
-
University Hospital, Clermont-FerrandUkjent
-
Medical College of WisconsinFullførtKommunikasjon | PasientengasjementForente stater
-
VA Greater Los Angeles Healthcare SystemRekrutteringPosttraumatisk stresslidelseForente stater
-
Boston University Charles River CampusRekrutteringPsykiske lidelser | Arbeid | Sysselsetting, støttet | MetakognisjonForente stater
-
University of British ColumbiaFullført
-
Ankara Yildirim Beyazıt UniversityFullførtOsteoporose | Sunn livsstil | Universitets studenterTyrkia
-
Henry M. Jackson Foundation for the Advancement...Uniformed Services University of the Health Sciences; ExThera Medical CorporationAktiv, ikke rekrutterende
-
Skin Analytics LimitedFullførtBasalcellekarsinom | Plateepitelkarsinom | Ondartet hudmelanom T0Forente stater, Italia
-
Skin Analytics LimitedInnovate UKFullført